McLean1.jpg (1194 bytes)MGHcjo.jpg (7744 bytes)HVDcjo.jpg (9168 bytes) NRLbanner400.JPG (18205 bytes)
Director: Prof. Ole Isacson, Biography and Research
Search Contact and Directions
 

MailmanRC.gif (6273 bytes)

Virtual Tour of McLean

Goals Staff Research Collaborators Funding Training Employment News Links Social Events

Udall Parkinson's Disease Research Center of Excellence

Diseasebar.gif (689 bytes)

Parkinson's Disease Program
Huntington's Disease Program
Alzheimer's Disease Project
Amyotrophic Lateral Sclerosis
Researchbar.gif (701 bytes)

Research Articles
In the News
Job Listings & Positions
conferencebar.gif (897 bytes)

McLean/Harvard Udall Res Centers of Excellence Seminar Series
Days of Molecular Medicine 2008,
Karolinska Institute,
Stockholm, Sweden

PAN forum - Webcast Link

CMT Conferences


IN THE NEWS AND MEDIA

Reprogrammed adult skin cells treat Parkinson's disease in animal model
HarvardScience Online; April 10, 2008
Article Link

Stem Cells from Skin Treat Brain Disease in Rats
Reuters Online; April 7, 2008
Article Link

Parkinson's Brain Cell Transplants Last for Years
Reuters Online; April 6, 2008
Article Link

FRONTLINE: A Report on Parkinson's Disease
Coming soon to PBS; Spring 2008
Video Highlights

March/April 2008 Neurosurgical Focus Interview
Ole Isacson and Nathan Selden; Stem Cell & Nervous System Therapeutics

Listen to the Interview:
Or Download to iTunes (Mac users control-click on link, PC users right-click)

Partnership is a Real No-Brainer; Dal-Harvard to Work Together on Brain Repair
The Chronicle Herald; February 21, 2008
Article Link

RECENT RESEARCH ARTICLES

Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years
Nature Medicine; Published online: April 6, 2008.
Abstract from Nature Medicine
PDF File


Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease
Proceedings of the National Academy of Sciences; Published online: April, 2008.
Abstract from HighWire
PDF File


Embryonic Stem (ES) Cell-derived Pitx3-eGFP Midbrain Dopamine Neurons Survive Enrichment by FACS and Function in an Animal Model of Parkinson's Disease
Stem Cells; Epub April 3, 2008.
Abstract from PubMed
PDF File


Recent advances in cell-based therapy for Parkinson disease
Neurosurg Focus; January 1, 2008 24(3-4): E6.
Abstract from HighWire
PDF File


Neuroinflammation mediated by IL-1 beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
J Neuroinflammation; February 27, 2008; 5(1): 8.
Abstract from HighWire
PDF File


Neural precursors derived from human embryonic stem cells maintain long-term proliferation without losing the potential to differentiate into all three neural lineages, including dopaminergic neurons
Journal of Neurochemistry; Jan. 2008; 104(2):316-24. Epub Oct. 18, 2007.
Abstract from PubMed
PDF File

Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson’s disease
Neurobiology of Disease; Jan. 2008; 29(1):103-16. Epub Aug. 28, 2007.
Abstract from PubMed
PDF File

Inhibition of the Leucine-rich Repeat Protein LINGO-1 Enhances Survival, Structure, and Function of Dopaminergic Neurons in Parkinson's Disease Models
Proceedings of the National Academy of Sciences; Aug. 28, 2007
Abstract
PDF File
Press Release

An Endogenous Serine/Threonine Protein Phosphatase Inhibitor, G-Substrate, Reduces Vulnerability in Models of Parkinson's Disease
The Journal of Neuroscience; August 1, 2007
Abstract
PDF File
Highlight



Mailman Research Center

   

RECENT PUBLICATIONS

Embryonic Stem (ES) Cell-derived Pitx3-eGFP Midbrain Dopamine Neurons Survive Enrichment by FACS and Function in an Animal Model of Parkinson's Disease.
Hedlund et al. Stem Cells, 2008 Abstract PDF

Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease.
Redmond et al. Neurobiology of Disease, 2007 Abstract PDF

Cell therapy and stem cells in animal models of motor neuron disorders.
Hedlund et al. Eur. J. Neurosci. 2007 Abstract PDF

Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models.
Inoue et al. Proc. Natl. Acad. Sci., August 28 2007 Abstract PDF

An Endogenous Serine/Threonine Protein Phosphatase Inhibitor, G-Substrate, Reduces Vulnerability in Models of Parkinson’s Disease.
Chung et al. J. Neurosci., August 2007 Abstract PDF

In vivo evidence of D(3) dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias.
Sánchez-Pernaute et al. Neurobiol Dis., May 2007 Abstract PDF

Markers and Methods for Cell Sorting of Human Embryonic Stem Cell-derived Neural Cell Populations.
Pruszak et al. Stem Cells, June 2007 Abstract PDF

Selection of Embryonic Stem Cell-Derived Enhanced Green Fluorescent Protein-Positive Dopamine Neurons Using the Tyrosine Hydroxylase Promoter Is Confounded by Reporter Gene Expression in Immature Cell Populations.
Hedlund et al. Stem Cells, May 2007 Abstract PDF

Inhibition of the dopamine D1 receptor signaling by PSD-95.
Zhang et al. J. Biol. Chem., March 2007 Abstract PDF

Proteasome Activator Enhances Survival of Huntington's Disease Neuronal Model Cells.
Seo et al. PLoS ONE February 2007 Abstract PDF

Enhanced Yield of Neuroepithelial Precursors and Midbrain-Like Dopaminergic Neurons from Human Embryonic Stem Cells Using the Bone Morphogenic Protein Antagonist Noggin.
Sonntag et al. Stem Cells Vol. 25 No. 2. February 2007 Abstract PDF

Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft.
Ferrari et al. Eur. J. Neurosci. October 2006 Abstract PDF

Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro.
Chung et al. Stem Cells. March 16, 2006 Abstract PDF

Specific microRNAs modulate ES cell-derived neurogenesis.
Krichevsky et al. Stem Cells Vol. 24 No. 4 April 2006 Abstract PDF

Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (Cyno1) after transplantation.
Sanchez-Pernaute et al. Stem Cells. June 7, 2005 Abstract PDF

Cell type specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.
Chung CY et al. Hum Mol Genet. May 11, 2005 Abstract PDF

Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.
Mendez et al. Brain Advance Access published online on May 4, 2005 Abstract PDF

Netrin-1 and slit-2 regulate and direct neurite growth of ventral midbrain dopaminergic neurons.
Lin et al. Mol Cell Neurosci. March 28, 2005 Abstract PDF

Context-dependent neuronal differentiation and germ layer induction of Smad4-/- and Cripto-/- embryonic stem cells.
Sonntag et al. Mol Cell Neurosci. March 28, 2005 Abstract PDF

TGF alpha induced adult neurogenesis does not produce dopamine neurons in PD model.
Cooper and Isacson J. Neurosci. October 13, 2004 Abstract PDF

Generalized proteasome inhibition in HD and convergent multiple cellular pathologies in vulnerable brain regions.
Seo et al. Ann. Neurol. September 2004 Abstract PDF

Countway Medical Library, Harvard University


Home Search Contact

MailmanRC.gif (6273 bytes)

 © All Rights Reserved.
Copyright © 2000 Center for Neuroregeneration Research
Site Contact: Sandra Pohlman - spohlman@mclean.harvard.edu

 


lab.neuroregeneration.org

neuroregeneration.org:325/projects
TC Calendar

System Contact: PageServant 
Last modified: Thursday, December 30, 2004